Skip to main content

Table 3 Characteristics of HPV + participants by whether or not they successfully presented for treatment

From: Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study

Variable

Total N

Unable to present for treatment

(no-show)

%

Presented for treatment

%

Unadjusted Odds Ratio of Presenting for Treatment

(95% CI)

Total (N, %)

N = 46

N = 23 (49%)

N = 24 (51%)

 

Age (mean, SD)

34 (12)

31 (11)

36 (12)

1.04 (0.99–1.10)

Age: categorical

 25–29 yo

24

58

42

0.29 (0.05–1.78)

 30–39 yo

12

50

50

0. 40 (0.05–2.93)

 40–49 yo

4

25

75

1.20 (0.07–19.63)

  > = 50 yo

7

29

71

1.0

Prior Screening HIstory

 None prior

38

50

50

1.0

 Prior screening

9

44

56

1.25 (0.29–5.39)

HIV serostatus

 HIV-

34

47

53

1.0

 HIV+

12

50

50

0.89 (0.24–3.32)

Family Planning

 No method

29

48

52

1.0

 Using a method

18

50

50

0.93 (0.29–3.03)

Pregnant

 Not pregnant

42

48

52

1.0

 Currently pregnant

3

100

0

too few observations

Have access to a mobile phone

 No access

8

63

37

1.0

 Has phone

39

46

54

1.94 (0.41–9.29)

Notification of test results via:

 Text

17

53

47

1.0

 Phone call

11

55

45

0.94 (0.20–4.29)

 Home visit

12

25

75

3.38 (0.67–17.00)

 Clinic visit

7

71

29

0.45 (0.34–2.30)